Ohr Pharmaceutical (OHRP) Presents Additional Data from IMPACT Study; Shows Early Regression of SHRM in wet-AMD
Tweet Send to a Friend
Ohr Pharmaceutical (Nasdaq: OHRP) announced the presentation of new data from the IMPACT study interim analysis at the 38th Annual ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
